Clinical Trial Update: A Study for Patients With Recurrent or Metastatic Squamous Cell Head and Neck Cancer [Phase 2]

View source ↗

Summary

Results from a Phase 2 trial for recurrent or metastatic head and neck squamous cell carcinoma sponsored by Eli Lilly; trial has completed and results were post…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Squamous Cell Carcinoma

Snippet

Sponsor: Eli Lilly and Company | Conditions: Head and Neck Neoplasms | Phase 2 | Status: COMPLETED | Results posted: 2013-03-19